Patent · US Active

OxMIF as a diagnostic marker

US9958456B2 · kind B2 · utility

0Cited by

30References

11Claims

0Family size

Assignee

Baxalta Incorporated · CH

Inventors

Michael Thiele · Wien, AT
Randolf Kerschbaumer · Klosterneuburg, AT
Dirk Voelkel · Weinheim, DE
Patrice Douillard · Wien, AT
Friedrich Scheiflinger · Wien, AT

Key dates

Filing date	Oct 4, 2012
Grant date	May 1, 2018
Priority date	—
Expiry date	Oct 4, 2032

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/70
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention pertains to the recognition that a specific oxMIF form of MIF is useful as a diagnostic marker in (MIF-related) diseases, in particular for example monitoring of disease progression. The present invention also pertains to the respective use of a diagnostic kit and a respective diagnostic assay and pertains to advantageous respective antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.